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Abstract
Background: Evidence from published literature in pharmacy practice research demonstrate that the use of
competency frameworks alongside standards of practice facilitate improvement in professional performance and
aid expertise development. The aim of this study was to evaluate pharmacists’ perception of relevance to practice
of the competencies and behaviours contained in the FIP Global Competency Framework (GbCF v1). The overall
objective of the study was to assess the validity of the GbCF v1 framework in selected countries in Africa.
Methods: A cross-sectional survey of pharmacists practicing in 14 countries in Africa was conducted between
November 2012 and December 2014. A combination of purposive and snowball sampling method was used. Data
was analysed using SPSS v22.
Results: A total of 469 pharmacists completed the survey questionnaire. The majority (91%) of the respondents were
from four countries: Ghana, Kenya, Nigeria and South Africa. The study results showed broad agreement on relevance
to practice for 90% of the behaviours contained in the GbCF v1 framework. Observed disagreement was associated
with area of pharmacy practice and the corresponding patient facing involvement (p≤ 0.05). In general, the competencies
within the ‘pharmaceutical care’ and ‘pharmaceutical public health’ clusters received higher weighting on relevance
compared to the research-related competencies which had the lowest. Specific inter-country variability on weighting
of relevance was observed in five behaviours in the framework although, this was due to disparity in ‘degree of relevance’
that was related to sample composition in the respective countries.
Conclusion: The competencies contained in the GbCF v1 are relevant to pharmacy practice in the study population;
however, there are some emergent differences between the African countries surveyed. Overall, the findings provide
preliminary evidence that was previously lacking on the relevance of the GbCF v1 competencies to pharmacy practice
in the countries surveyed.
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Background
Competent pharmacists improve therapeutic outcomes,
minimise the risk associated with medicines use and assure
patient safety through the provision of medicine expertise
[1–5]. The central role pharmacists play within the health
system underpins the demand for a competent and highly
skilled workforce that is equipped with the requisite know-
ledge and skills relevant to population health needs [6–8].
This is of particular importance in resource-limited settings
such as in sub-Saharan Africa where severe workforce short-
ages hamper access to health services including medicines
expertise [9, 10].
The International Pharmaceutical Federation (FIP) is the
global leadership body representing 3 million pharmacists
and pharmaceutical scientists worldwide [11]. FIPEd, which
is the pharmacy education and workforce development arm
of the FIP, advocates the need to define and articulate the
competencies that pharmacists require to consistently
perform safely, effectively, and efficiently [12]. The overall
objective is to provide an infrastructure for global guidance* Correspondence: i.bates@ucl.ac.uk
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on the practice-based expectations of the pharmacy work-
force [13].
Published research demonstrate that when competency
frameworks are used alongside standards of practice: it
facilitates improvement of pharmacists’ performance [14–17],
promotes the attainment and maintenance of fitness to
practice [17, 18], aids identification of knowledge gaps and
learning needs [19], and fosters continuing professional devel-
opment [20]. The findings of longitudinal studies show that
using competency frameworks to identify knowledge gaps
and tailor learning activities significantly improve pharmacists’
performance (p ≤ 0.05) at 6 months [14, 15, 17], 9 months
[16], and 12 months [18, 20]. Similar findings from compara-
tive studies conducted in United Kingdom [14, 20] indicate
that competency frameworks facilitate a more sustained
improvement in pharmacists’ performance (p < 0.001) in the
intervention group at 12 months when compared to a control
group that had no access to a framework. These findings have
also been corroborated by other studies in Australia [15],
Croatia [18], Serbia [17], and Singapore [16].
In 2012, FIPEd developed the FIP Global Competency
Framework (GbCF v1) using evidence-based methodologies
[21]. This framework was specifically designed to serve as a
source document containing the core competencies
expected of foundation level pharmacy practitioners (this
means, pharmacists with less than 5 years practice experi-
ence) [13]. Since its development, the GbCF v1 has been
successfully used to design pre-service education and train-
ing curriculum in a number of countries [22, 23]. It has also
been used to develop country-specific frameworks for in-
service practitioners in Ireland [24], the Pacific Island coun-
tries [25], Croatia, Singapore and Serbia [21]. A previous
survey that validated the GbCF v1 using evidence from 64
countries [26] showed that 70% of respondents ranked all
the behaviours in the questionnaire as relevant to practice.
However, respondents from countries in Africa comprised
only 12.3% of the total sample in the survey [26]. The aim of
this present study was therefore to evaluate pharmacists’
perception of the relevance to practice of the competencies
and behaviours contained in the GbCF v1, focusing on
selected African countries.
Methods
Data collection and sampling
A cross-sectional survey of pharmacists practicing in selected
countries in Africa was conducted between November 2012
and December 2014. A combination of purposive and snow-
ball sampling method was used. Due to a lack of access to
the pharmacy membership list of the respective countries in
Africa, the URL link to the online survey was circulated
centrally via email to the 35 FIP member organisations in
Africa for onward distribution to their respective individual
members. The FIP member organisations contacted were
the leadership bodies representing practicing pharmacists in
24 countries in Africa (list provided in the Appendix). These
organisations were selected based on availability of contact
persons, expression of interest to participate when contacted
and willingness to gather data. The survey invite was also dis-
seminated through the FIP United Nations Education Scien-
tific and Cultural Organisation (UNESCO) University
Twining Network (FIP UNESCO UNITWIN) in Africa. The
survey URL link was further customised and distributed via
social media and short message service platforms including
Facebook®, Twitter®, WhatsApp® and Blackberry Messenger®.
Respondents were encouraged to assist by forwarding the
survey URL link to their colleagues and contacts. Email
reminders were thereafter forwarded monthly through the
aforementioned media until the end of the study. Due to the
non-availability of reliable estimates on the number of
pharmacists per country organisation represented in FIP, a
sampling frame was not feasible and survey respondents
were therefore recruited consecutively until the end of the
study period.
Survey questionnaire
An anonymous online questionnaire developed and vali-
dated in a previous study [26] was used. The questionnaire
was fully reproduced from the GbCF v1 and comprised of
105 questions. Five questions related to demographic infor-
mation while the remaining questions referred to the 100
GbCF v1 behavioural statements (labelled B1 through B100,
and hereafter referred to as ‘behaviours’). These behaviours
are grouped under the 20 competency domains and four
broad competency clusters in the framework (Table 1).
Data analysis
Survey data was collected electronically, without transform-
ation and analysed using the Statistical Package for the
Social Sciences (SPSS) version 22. To ensure data quality, a
random 10% of the total survey sample was reviewed for
coding errors with missing values replaced with code 999.
Respondents’ perception of relevance to practice of each of
the behaviours was evaluated using a 4-point Likert scale.
Respondents were required to rank each of the 100 GbCF
v1 behaviours as ‘not relevant’, of ‘low relevance’, ‘relevant’ or
‘highly relevant’ to their practice. For the purpose of analysis
and to ensure the results produced could be meaningfully
interpreted, the response categories in the Likert scale were
further aggregated. The ‘highly relevant’ and ‘relevant’
ratings were condensed into one category: ‘relevant’, while
the ‘low relevance’ and ‘not relevant’ ratings remained
distinct categories. Agreement was evaluated by comparing
the proportion (frequency and percentage) of the total
ratings in the three categories. Consensus on relevance to
practice was attained when not more than 10% of the
respondents ranked a given behaviour as ‘not relevant’. This
threshold was defined empirically based on previous
research involving pharmacists from 64 countries [26].
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Pearson’s chi-square (χ2) test was used to assess
homogeneity in the survey sample. The test of homogeneity
was undertaken to ascertain whether the sample could be
treated as a group irrespective of the number of replies
received per country. The χ2 test was also used to evaluate
the relationship between weighting of relevance and area of
practice for behaviours that showed a lack of consensus. In
order to assess inter-country variability in responses, multi-
variate analysis of variance (MANOVA) via Pillia’s trace test
(V) was used to evaluate weighting of relevance per country
per competency with confirmatory post hoc analysis con-
ducted using Bonferroni correction.
Ethical consideration
Formal ethical approval from the research ethics committee
was not required for this study as it did not involve the use
of identifiable patient information or data, rather the study
recruited pharmacists and sought their views by virtue of
their professional roles. However, consent to participate
was sought from the respondents prior to completing the
survey questionnaire. Participation was voluntary, and
confidentiality was maintained at all times with responses
remaining anonymous. All data collected in the research
were stored in an encrypted database with hard copies kept
in locked filling cabinets at the Department of Practice and
Policy, UCL School of Pharmacy, United Kingdom. Access
to study data was restricted to the three researchers directly
involved with the study.
Results
Demography
Four hundred and sixty-nine pharmacists from 14 countries
in Africa responded to the survey. Over half of the survey
respondents were female (54%). The mean length of practice
was 7.7 years (SD± 8.1 years; min–max 1–43 years). Re-
spondents with less than 5 years practice experience made
up 47% of the sample while pre-registration candidates/
pharmacy students in their last year (internship) comprised
5.5%. The majority of the respondents were in hospital prac-
tice (56.7%). Table 2 shows the summary of the distribution
of survey replies per country and area of pharmacy practice.
Sample homogeneity
Four countries—Kenya, Nigeria, South Africa and Ghana—
each had more than 50 replies and made up 91% of the sam-
ple. Ten countries—Ethiopia, Egypt, Lesotho, Uganda,
Tunisia, Namibia, Sudan, Tanzania, Zambia and Zimbabwe—
had fewer than 20 survey replies each. The observed disparity
in number of replies indicated two cluster groups: a ‘high
response group’ made up of countries with more than 50
Table 2 Survey replies per country per area of pharmacy practice
Area of practice Country N (%)
Kenya Ghana Nigeria South Africa Others a
Academic pharmacy 1 (1.0) 4 (4.3) 11 (6.6) 21 (32.8) 6 (14.0)
Administrative pharmacy 6 (5.8) 13 (14.0) 4 (2.4) 2 (3.1) 4 (9.3)
Community pharmacy 2 (1.9) 10 (10.8) 41 (24.7) 10 (15.6) 10 (23.3)
Hospital pharmacy 89 (86.4) 60 (64.5) 80 (48.2) 23 (35.9) 14 (32.6)
Industrial pharmacy 1 (1.0) 3 (3.2) 26 (15.7) 6 (9.4) 5 (11.6)
Othersb 4 (3.9) 3 (3.2) 4 (2.4) 2 (3.1) 4 (9.3)
Total sample 103 (22) 93 (19.8) 166 (35.4) 64 (13.6) 43 (9.2)
aCountries with fewer than 50 replies each [includes Zambia [15], Egypt [8], Zimbabwe [5], Uganda [3], Lesotho [3], Tunisia [5], Namibia, Ethiopia Sudan and
Tanzania (1 each)]
bAreas of pharmacy practice with fewer than 20 replies [includes pharmacy information [11], military and emergency [2] and laboratory and medicines control
pharmacy [4]]
Table 1 Components of the GbCF v1 framework
Cluster Composition and description
Pharmaceutical public health Four behaviours labelled B1–B4 grouped under two competencies:
‘health promotion’ and ‘medicines information and advice’
Pharmaceutical care 25 behaviours labelled B5–B29 grouped under six competencies: ‘assessment of medicines’,
‘dispensing’, ‘medicines’, ‘monitor medicines therapy’, ‘patient consultation and diagnosis’
Organisation and management 32 behaviours labelled B30–B61 grouped under six competencies: ‘budget and reimbursement’,
‘human resource management’, ‘improvement of service’, ‘procurement’, ‘supply chain and
management’, and ‘work place management’
Professional and personal 39 behaviours labelled B62–B100 grouped under six competencies: ‘communication skills’,
‘continuing professional education’, ‘legal and regulatory practice’, ‘professional and ethical
practice’, ‘quality assurance and research in the workplace’, ‘self-management’
Udoh et al. Human Resources for Health  (2018) 16:16 Page 3 of 15
replies each, and a ‘low response group’ made up of countries
with fewer than 20 replies each. The number of replies also
varied for the four competency clusters in the framework.
Table 3 shows a summary of the distribution of replies for
each competency cluster per country group.
The test for homogeneity in the survey sample showed that
distribution of the ratings in the response categories (that is,
in the ‘relevant’, ‘low relevance’ and ‘not relevant’ categories)
was strongly associated with the country group for 11 behav-
iours [(p < 0.01); Table 4]. These 11 behaviours were distrib-
uted across the four competency clusters in no observable
pattern. The outcome of the χ2 test implied homogeneity in
responses between the country groups for 89% of the GbCF
v1 behaviours. The low counts (frequency of less than 5)
observed in the table cells within the group with low number
of replies (N< 20 per country; Table 4) suggested an absence
of data in this group rather than disparity in responses
between countries. Given the χ2 test known property of being
imprecise in ‘small’ samples [27–29], it is likely that the test
overestimated the relationship between the responses and the
country group. Based on this, sample homogeneity was
assumed and the survey replies were subsequently analysed
as a group. Figure 1 shows the percentage of ratings in the
‘relevant’ category for the low response, high response, and
Table 4 Behaviours showing association with country response group
Cluster Competency Behaviour High response countries (N) Low response countries (N) χ2
value
p
Not
relevant
Low
relevance
Relevant Not
relevant
Low
relevance
Relevant
Pharmaceutical
public health
Health
promotion
[B1] Assess primary healthcare needs 10 20 396 1* 7 35 9.67 0.01
Medicines
information
and advice
[B4] Identify sources, retrieve, evaluate,
assess and disseminate relevant
medicines information according to
patients needs
2* 22 402 1* 8 34 1.12 0.01
Pharmaceutical
care
Assessment
of medicines
[B6] Identify and act upon medicines
interactions
40 68 242 3* 15 18 9.56 0.01
Dispensing [B12] Dispense devices (e.g. inhalers) 11 18 321 0* 9 27 20.54 < 0.001
Medicines [B19] Ensure appropriate medicine
route, dose, time, form and response
for individual patients
22 21 307 5 7 24 12.52 0.002
Organisation
and
management
Human
resource
management
[B37] Participate and collaborate,
advice in therapeutic decision-making
and use appropriate decision referral
in a multi-disciplinary team
11 23 261 4* 6 23 9.4 0.01
Improvement
of service
[B42] Resolve, follow-up and prevent
medicines related problems
10 23 262 1* 9 23 12.8 < 0.001
Procurement [B44] Develop and implement a
contingency plan for shortages
11 27 257 5 2* 26 8.5 0.01
Supply chain
management
[B54] Implement system for
documentation and record keeping
11 13 271 3* 8 22 22.35 0.001
Work place
management
[B61] Recognise and manage
pharmacy resources (e.g. financial,
infrastructure)
9 26 260 5 3* 25 10.71 0.01
Professional
and personal
Quality
assurance and
research in the
workplace
[B94] Implement, conduct and
maintain a report system of
pharmacovigilance (e.g. report
adverse drug reactions)
16 11 246 2* 6 24 11.88 0.003
*Counts of less than 5
Table 3 Distribution of survey replies per competency cluster per country response group
Competency cluster Behaviour label Country response group (N)a
Countries with high responseb Countries with low responsec
Pharmaceutical public health B1–B4 426 43
Pharmaceutical care B5–B29 350 36
Organisation and management B30–B61 295 33
Professional and personal B62–B100 273 32
aCountries with more than 50 replies each were regrouped as the high response group while countries with fewer than this were the low response group
bIncludes Ghana, Kenya, Nigeria and South Africa
cIncludes Zambia, Egypt, Zimbabwe, Uganda, Lesotho, Tunisia, Namibia, Ethiopia Sudan and Tanzania
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combined group of countries, respectively. The total ratings
in the combined country groups indicate that at least 70% of
survey respondents ranked all the behaviours in the
framework as ‘relevant’. This was not inclusive of the ‘not
relevant’ and ‘low relevant’ ratings.
Overall perception of relevance
Consensus on relevance to practice (N ‘not relevant’ < 10%)
was obtained for 90 behaviours in the questionnaire. This
included all the behaviours in the ‘pharmaceutical public
health’ cluster, 84% in the ‘pharmaceutical care’, 90% in
‘organisation and management’ and 92% in the ‘professional
and personal’ cluster, respectively (please see Tables 5, 6, 7
and 8). The 10 behaviours with more than 10% of the total
ratings in the ‘not relevant’ category, suggested disagree-
ment on relevance to practice (Table 9). This observed
disagreement was associated with area of pharmacy practice
for six of the ‘disagreed’ behaviours (Table 9; P < 0.05).
Table 5 Overall rating of behaviours within the pharmaceutical public health cluster
Pharmaceutical public health competencies (n = 469) Not relevant Low relevance Relevant Group
Count Row
(N%)
Count Row
(N%)
Count Row
(N%)
Health promotion
B1. HP | Assess the primary healthcare needs (taking into account the cultural and
social setting of the patient)
11 2.30 27 5.8 431 91.9 1
B2. HP | Advise on health promotion, disease prevention and control, and healthy
lifestyle
2 0.4 26 5.5 441 94 1
Medicines information and advice
B3. MIA | Counsel patients on the appropriate use of medicines and devices (including
the selection, use, contraindications, storage, and side effects of non-prescription
and prescription medicines) taking into account patients preferences
3 0.60 23 4.90 443 94.4 1
B4. MIA | Identify sources, retrieve, evaluate, organise, assess and disseminate relevant
medicines information according to the needs of patients and clients and provide
appropriate information
3 0.60 30 6.40 436 92.9 1
Behaviours that showed agreement (this means, N ‘not relevant’ ≤ 10%) were categorised as group 1; group 2 behaviours showed disagreement on relevance
(N ‘not relevant’ > 10%)
Fig. 1 Percentage of total ratings in the ‘relevant’ category per behaviour (not inclusive of ratings in the ‘low relevance’ and ‘not relevant’ categories).
Numbers on the circumference refer to behaviour labels (1 through 100) while numbers on the vertical axis refer to percentage of total ratings
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Table 6 Overall rating of behaviours in the pharmaceutical care cluster
Pharmaceutical care competencies (n = 386) Not relevant Low relevance Relevant Group
Count Row (N%) Count Row (N%) Count Row (N%)
Assessment of medicines
B5. AM | Appropriately select medicines (e.g. according to the patient, hospital,
government policy, etc.)
18 4.7 40 10.4 328 85 1
B6. AM | Identify, prioritise and act upon medicine-medicine interactions;
medicine-disease interactions; medicine-patient interactions; medicines-food
interactions
43 11.1 83 21.5 260 67.4 2
Compounding medicines
B7. CM | Prepare pharmaceutical medicines (e.g. extemporaneous, cytotoxic medicines),
determine the requirements for preparation (calculations, appropriate formulation,
procedures, raw materials, equipment etc.)
25 6.5 61 15.8 300 77.7 1
B8. CM | Compound under the good manufacturing practice for pharmaceutical (GMP)
medicines
35 9.1 61 15.8 290 75.1 1
Dispensing
B9. D | Accurately dispense medicines for prescribed and/or minor ailments and monitor
the dispense (re-checking the medicines)
19 4.9 43 11.2 324 83.9 1
B10. D | Accurately report defective or substandard medicines to the appropriate
authorities
26 6.7 53 13.7 307 79.5 1
B11. D | Appropriately validate prescriptions, ensuring that prescriptions are correctly
interpreted and legal
16 4.1 41 10.6 329 85.2 1
B12. D | Dispense devices (e.g. Inhaler or a blood glucose meter) 11 2.8 27 7 348 90.2 1
B13. D | Document and act upon dispensing errors 50 13 44 11.4 292 75.6 2
B14. D | Implement and maintain a dispensing error report system and a ‘near misses’
report system
43 11.1 46 11.9 297 76.9 2
B15. D | Label the medicines (with the required and appropriate information) 14 5.2 20 3.6 352 91.2 1
B16. D | Learn from and act upon previous ‘near misses’ and ‘dispensing errors 19 4.9 27 7 340 88.1 1
Medicines
B17. M | Advise patients on proper storage conditions of the medicines and ensure that
medicines are stored appropriately (e.g. humidity, temperature, expiry date, etc.)
17 4.9 19 4.4 350 90.7 1
B18. M | Appropriately select medicines formulation and concentration for minor
ailments (e.g. diarrhoea, constipation, cough, hay fever, insect bites, etc.)
33 8.5 42 10.9 311 80.6 1
B19. M | Ensure appropriate medicines, route, time, dose, documentation, action, form
and response for individual patients
27 7 28 7.3 331 85.8 1
B20. M | Package medicines to optimise safety (ensuring appropriate re-packaging and
labelling of the medicines)
39 10.1 47 12.2 300 77.7 2
Monitor medicines therapy
B21. MMT | Apply guidelines, medicines formulary system, protocols and treatment
pathways
11 4.9 19 2.9 356 92.2 1
B22. MMT | Ensure therapeutic medicines monitoring, impact and outcomes (including
objective and subjective measures)
22 5.7 26 6.7 338 87.6 1
B23. MMT | Identify, prioritise and resolve medicines management problems (including
errors)
12 3.1 19 4.9 355 92 1
Patient consultation and diagnosis
B24. PCD | Apply first aid and act upon arranging follow-up care 18 4.7 29 7.5 339 87.8 1
B25. PCD | Appropriately refer 14 3.6 18 4.7 354 91.7 1
B26. PCD | l Assess and diagnose based on objective and subjective measures 12 3.1 21 5.4 353 91.5 1
B27. PCD | Discuss and agree with the patients the appropriate use of medicines, taking
into account patients preferences
14 3.6 30 7.8 342 88.6 1
B28. PCD | Document any intervention (e.g. document allergies, medicines and food, in
patient medicines history)
21 5.4 43 11.1 322 83.4 1
B29. PCD | Obtain, reconcile, review, maintain and update relevant patient medication
and diseases history
18 4.7 28 7.3 340 88.1 1
Group: 1 = agreement, 2 = disagreement
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Table 7 Overall rating of behaviours in the organisation and management cluster
Organisation and management competencies (n = 328) Not relevant Low relevance Relevant Group
Count Row
(N%)
Count Row
(N%)
Count Row
(N%)
Budget and reimbursement
B30. BR | Acknowledge the organisational structure 16 4.9 45 13.7 267 81.4 1
B31. BR | Effectively set and apply budgets 20 6.1 53 16.2 255 77.7 1
B32. BR | Ensure appropriate claim for the reimbursement 40 12.2 54 16.5 234 71.4 2
B33. BR | Ensure financial transparency 21 6.4 45 13.7 262 79.9 1
B34. BR | Ensure proper reference sources for service reimbursement 34 10.4 56 17.1 238 72.5 2
Human resources management
B35. HRM | Demonstrate organisational and management skills (e.g. Know, understand
and lead on medicines management; risk management; self-management;
time management; people management; project management;
policy management.)
8 2.4 23 7 297 90.6 1
B36. HRM | Identity and manage human resources and staffing issues 13 4 37 11.3 278 84.8 1
B37. HRM | Participate, collaborate, advice in therapeutic decision-making and use
appropriate referral in a multi-disciplinary team
15 4.6 29 8.8 284 86.6 1
B38. HRM | Recognise and manage the potential of each member of the staff and
utilise systems for performance management (e.g. carry out staff appraisals)
12 3.7 33 10.1 283 86.3 1
B39. HRM | Recognise the value of the pharmacy team and of a multidisciplinary team 7 2.1 25 7.6 296 90.2 1
B40. HRM | Support and facilitate staff training and professional development 9 2.7 23 7 296 90.2 1
Improvement of service
B41. IS | Identify and implement new services (according to local needs) 7 2.1 35 10.7 286 87.2 1
B42. IS | Resolve, follow up and prevent medicines related problems 11 3.4 32 9.8 285 86.9 1
Procurement
B43. P | Access reliable information and ensure the most cost-effective medicines in
the right quantities with the appropriate quality
12 3.7 20 6.1 296 90.2 1
B44. P | Develop and implement contingency plan for shortages 16 4.9 29 8.8 283 86.3 1
B45. P | Efficiently link procurement to formulary, to push/pull system (supply chain
management) and payment mechanisms
18 5.5 44 13.4 266 81.1 1
B46. P | Ensure there is no conflict of interest 19 5.8 43 13.1 266 81.1 1
B47. P | Select reliable suppliers of high-quality products (including appropriate
selection process, cost effectiveness, timely delivery)
16 4.9 32 9.8 280 85.4 1
B48. P | Supervise procurement activities 23 7.0 34 10.4 271 82.6 1
B49. P | Understand the tendering methods and evaluation of tender bids 25 7.6 50 15.2 253 77.1 1
Supply chain and management
B50. SCM | Demonstrate knowledge in store medicines to minimise errors and
maximise accuracy
15 4.6 20 6.1 293 89.3 1
B51. SCM | Ensure accurately verification of rolling stocks 16 4.9 30 9.1 282 86 1
B52. SCM | Ensure effective stock management and running of service with the
dispensary
17 5.5 18 5.2 293 89.3 1
B53. SCM | Ensure logistics of delivery and storage 16 4.9 23 7 289 88.1 1
B54. SCM | Implement a system for documentation and record keeping 14 4.3 21 6.4 293 89.3 1
B55. SCM | Take responsibility for quantification of forecasting 22 7.0 23 6.7 283 86.3 1
Work place management
B56. WPM | Address and manage day to day management issues 8 2.4 20 6.1 300 91.5 1
B57. WPM | Demonstrate the ability to take accurate and timely decisions and
make appropriate judgments
8 2.4 15 4.6 305 93 1
B58. WPM | Ensure the production schedules are appropriately plan and manage 35 10.7 52 15.9 241 73.5 2
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The disagreement was also associated with ‘patient-facing
role’ in practice area [(P < 0.05); Table 10]. A higher percent-
age of the respondents in the ‘non-patient’ facing areas of
practice (this means area of pharmacy practice with little or
no daily patient interactions such as industrial and academic
pharmacy) ranked the behaviours that showed disagreement
in the ‘pharmaceutical care’ (B6, B13, B14, B20) and ‘organ-
isation and management’ cluster (B32, B34, B58) as ‘not rele-
vant’ compared to respondents in the ‘patient-facing’ practice
areas (such as hospital and community pharmacy) (Table 10).
The converse was true for the research-related (B87 and
B95) and quality control (B90) behaviours (Table 10).
Perception of relevance per competency per country
Inter-country variability in responses was assessed for each
of the 20 competencies in the questionnaire. For ease of
interpretation, the analysis included 426 replies from four
countries: Kenya, Nigeria, South Africa and Ghana with the
10 countries that had fewer than 20 survey replies each
excluded. The result showed similarity in weighting of rele-
vance for the competencies in the ‘pharmaceutical public
health’ (Pillia’s trace V = 0.025, F = 1.809, df = 6, p = 0.094),
and ‘professional and personal’ (Pillia’s trace V = 0.084, F=
1.270, df = 18, p = 0.2) clusters, respectively. Specific inter-
country variability was observed in the ‘pharmaceutical
care’ (Pillia’s trace V = 0.083, F = 1.624, df = 18, p = 0.045),
and ‘organisation and management’ (Pillia’s trace V = 0.136,
F = 2.279, df = 18, p = 0.002) clusters.
Confirmatory post hoc analysis using Bonferroni cor-
rection showed the inter-country variability in responses
observed within the ‘pharmaceutical care’ cluster was in
three behaviours: B6 [‘assessment of medicine (AM)]’
and B25 and B27 [‘patient consultation and diagnosis
(PCD)’] competencies. This was between South Africa
and Ghana [in B6: N ‘relevant’ = 47% vs 71%)], Nigeria
and Kenya [in B25: N ‘relevant’ = 98 vs 89%], and Nigeria
and Ghana [in B27: N ‘relevant’ = 98 vs 85%)]. In spite of
the observed disparity in weighting of relevance, only
South Africa showed a lack of consensus on relevance
(N ‘not relevant’ = 15%) for this cluster and this was in
the B6 behaviour.
The disparity in the organisation and management cluster
was in B32 [‘budget and reimbursement (BR)’], B45 [‘pro-
curement (P)’] and B55 [‘supply chain and management
(SCM)’] competencies. More of the respondents from
Ghana rated the B32, B45 and B55 behaviours ‘relevant’
compared to Nigeria (75%, 92%, 94% vs 70%, 70%, 79%,
respectively). A lack of consensus on relevance was
observed in the South Africa and Nigeria group for the B32
(N ‘not relevant’ = 11%) and B49 (N ‘not relevant’= 11%)
behaviours, respectively. Since only Nigeria and South
Africa showed a lack of consensus (N ‘not relevant’ > 10%)
on relevance to practice for three behaviours in the frame-
work, it suggests that the inter-country variability in weight-
ing of relevance observed in this study indicated differences
in perception of ‘degree of relevance’ between countries.
This variability is likely due to the disparity in sample
composition in the respective countries given that
Kenya had a higher percentage of the respondents in
hospital practice (86%) while Nigeria and South Africa
on the other hand had less than 50% respectively. Also,
more than a third of the respondents from South Africa
were in academic pharmacy compared to Nigeria,
Kenya and Ghana with less than 7% each.
Discussion
The disagreement observed in 10 behaviours in the GbCF
v1 framework was mainly related to respondents’ area of
pharmacy practice and the corresponding patient-facing
involvement, a finding that is consistent with evidence from
previous research [26]. The disagreement in the four behav-
iours under the ‘pharmaceutical care’ cluster observed in
academic and industrial pharmacy is also in line with the
scope of practice of pharmacists in these areas given that
they are not routinely involved in activities related to medi-
cine assessment and medicines use. This also explains the
disagreement observed in the three behaviours under the
‘organisation and management’ cluster.
On the other hand, the disagreement in the research-
related behaviours (B87 and B95) under the ‘professional
and personal’ cluster was not fully explained by area of
pharmacy practice or ‘patient-facing’ involvement. A high
percentage (N > 10%) of the respondents in academic and
community pharmacy rated these same behaviours ‘not rele-
vant’, thereby adding to the increasing body of evidence from
other studies that suggest that pharmacists are not routinely
involved in research [30–33] and perceive their research-
related roles to be of low importance [34–37]. It also corrob-
orates the findings of published studies from Australia [38],
United Kingdom [39] and Thailand [40] that show that
Table 7 Overall rating of behaviours in the organisation and management cluster (Continued)
Organisation and management competencies (n = 328) Not relevant Low relevance Relevant Group
Count Row
(N%)
Count Row
(N%)
Count Row
(N%)
B59. WPM | Ensure the work time is appropriately plan and manage 10 3 23 7 295 89.9 1
B60. WPM | Improve and manage the provision of pharmaceutical services 8 2.4 20 6.1 300 91.5 1
B61. WPM | Recognise and manage pharmacy resources (e.g. financial, infrastructure) 14 4.3 29 8.8 285 86.9 1
Group: 1 = agreement, 2 = disagreement
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Table 8 Overall rating of behaviours in the professional and personal cluster
Professional and personal competencies (n = 305) Not relevant Low relevance Relevant Group
Count Row
(N%)
Count Row
(N%)
Count Row
(N%)
Communication skills
B62. CS | Communicate clearly, precisely and appropriately while being a mentor
or tutor
4 1.3 6 2 295 96.7 1
B63. CS | Communicate effectively with health and social care staff, support staff,
patients, carer, family relatives and clients/customers, using lay terms and
checking understanding
4 1.3 9 3 292 95.7 1
B64. CS | Demonstrate cultural awareness and sensitivity 6 2.0 17 5.6 282 92.5 1
B65. CS | Tailor communications to patient needs 5 1.6 15 4.9 285 93.4 1
B66. CS | Use appropriate communication skills to build, report and engage with
patients, health and social care staff and voluntary services (e.g. verbal and
non-verbal)
3 < 0.1 10 3.3 292 95.7 1
Continuing professional development (CPD)
B67. CPD | Document CPD activities 10 3.3 36 11.8 259 84.9 1
B68. CPD | Engage with students/interns/residents 12 3.9 28 9.2 265 86.9 1
B69. CPD | Evaluate currency of knowledge and skills 8 2.6 25 8.2 272 89.2 1
B70. CPD | Evaluate learning 8 2.6 25 8.2 272 89.2 1
B71. CPD | Identify if expertise needed outside the scope of knowledge 9 3.0 31 10.2 265 86.9 1
B72. CPD | Identify learning needs 7 2.3 28 9.2 270 88.5 1
B73. CPD | Recognise own limitations and act upon them 5 1.6 20 6.6 280 91.8 1
B74. CPD | Reflect on performance 4 1.3 14 4.6 287 94.1 1
Legal and regulatory practice
B75. LRP | Apply and understands regulatory affairs and the key aspects of
pharmaceutical registration and legislation
7 2.3 23 7.5 275 90.2 1
B76. LRP | Apply knowledge in relation to the principals of business economics
and intellectual property rights including the basics of patent interpretation
16 5.2 54 17.7 235 77.1 1
B77. LRP | Be aware of and identify the new medicines coming to the market 4 1.3 25 8.2 276 90.5 1
B78. LRP | Comply with legislation for drugs with the potential for abuse 5 1.6 11 3.6 289 94.8 1
B79. LRP | Demonstrate knowledge in Marketing and Sale 24 7.9 75 24.6 206 67.5 1
B80. LRP | Engage with health and medicines policies 3 < 0.1 31 10.2 271 88.9 1
B81. LRP | Understand the steps needed to bring a medicinal product to the
market including the safety, quality, efficacy and pharmacoeconomic
assessments of the product
18 5.9 41 13.4 246 80.7 1
Professional and ethical practice
B82. PEP | Demonstrate awareness of local/national codes of ethics 5 1.6 14 4.6 286 93.8 1
B83. PEP | Ensure confidentiality (with the patient and other healthcare
professionals)
4 1.3 10 3.3 291 95.4 1
B84. PEP | Obtain patient consent (it can be implicit in occasions) 10 3.3 21 6.9 274 89.8 1
B85. PEP | Recognise own limitations 5 1.6 14 4.6 286 93.8 1
B86. PEP | Take responsibility for own action and for patient care 5 1.6 11 3.6 289 94.8 1
Quality assurance and research in the work place
B87. QARWP | Apply research findings and understand the benefit risk
(e.g. pre-clinical, clinical trials, experimental clinical-pharmacological
research and risk management)
34 11.1 48 15.7 223 73.1 2
B88. QARWP | Audit quality of service (ensure that they meet local and national
standards and specifications)
26 8.5 34 11.1 245 80.3 1
B89. QARWP | Developed and implement Standing Operating Procedures (SOP’s) 17 5.6 17 5.6 271 88.9 1
B90. QARWP | Ensure appropriate quality control tests are performed and
managed appropriately
39 12.8 54 17.7 212 69.5 2
B91. QARWP | Ensure medicines are not counterfeit and quality standards 16 5.2 24 7.9 265 86.9 1
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pharmacists generally perceive research-related behaviours
and competencies included in developmental frameworks to
be relatively low in relevance and rank them accordingly.
Time constraints due to workload and a lack of supporting
environment for pharmacy research are some of the barriers
to participation in research-related activities in the work-
place reported in existing literature [38, 41, 42]. Given that
the survey respondents in our study included international
pharmacists from different areas of pharmacy practice and
with varying length of practice experience, this finding
Table 8 Overall rating of behaviours in the professional and personal cluster (Continued)
Professional and personal competencies (n = 305) Not relevant Low relevance Relevant Group
Count Row
(N%)
Count Row
(N%)
Count Row
(N%)
B92. QARWP | Identify and evaluate evidence-base to improve the use of medicines
and services
16 5.2 32 10.5 257 84.3 1
B93. QARWP | Identify, investigate, conduct, supervise and support research at the
workplace (enquiry-driven practice)
29 9.5 48 15.7 228 74.8 1
B94. QARWP | Implement, conduct and maintain a report system of pharmacovigilance
(e.g. report adverse drug reactions)
17 5.9 18 5.6 270 88.5 1
B95. QARWP | Initiate and implement audit and research activities 33 10.8 52 17.5 220 72.1 2
Self-management
B96. SM | Apply assertiveness skills (inspire confidence) 5 1.6 9 3 291 95.4 1
B97. SM | Demonstrate leadership and practice management skills, initiative and efficiency 4 1.3 12 3.9 289 94.8 1
B98. SM | Document risk management (e.g. critical incidents) 14 4.6 28 9.2 263 86.2 1
B99. SM | Ensure punctuality 1 < 0.1 10 3.3 294 96.4 1
B100. SM | Prioritise work and implement innovative ideas 4 1.3 12 3.9 289 94.8 1
Group: 1 = agreement, 2 = disagreement
Table 9 Distribution of the ‘not relevant’ ratings in relation to area of pharmacy practice for the 10 behaviours showing disagreement
Cluster Competencies Behaviours Area of practice (%N ‘not relevant’) χ2 value p
Acad. Admin. Comm. Hosp. Indus. Othersa
Pharmaceutical
care
Assessment
of medicines
[B6] Identify, prioritise and act upon
medicine-medicine interactions;
medicine-disease interactions;
medicine-patient interactions;
medicines-food interactions (n = 43)
20 9.5 0 11.6 21.9 7.1 23.5 0.01
Dispensing [B13] Document and act upon
dispensing errors (n = 50)
14.3 19 20 7.6 21.9 35.7 36.9 < 0.001
[B14] Implement and maintain a
dispensing error report system and
a ‘near misses’ report system (n = 43)
17.1 14.3 20.3 7.1 12.5 14.3 15.9 0.1
Medicines [B20] Package medicines to optimise
safety [ensuring appropriate re-packaging
and labelling of the medicines] (n = 39)
20 9.5 16.9 4.4 25 14.3 31.9 < 0.001
Organisation
and
management
Budget and
reimbursement
[B32] Ensure appropriate claim for
reimbursement (n = 40)
24 5 10.9 8.8 24 27.3 20.1 0.03
[B34] Ensure proper reference sources for
service reimbursement (n = 34)
18.2 5 10.9 7.8 16 27.3 16.8 0.08
Workplace
management
[B58] Ensure production schedules are
appropriately planned and managed (n = 35)
15.2 5 19.6 6.7 20 18.2 17.4 0.08
Professional
and personal
Quality
assurance and
research in the
workplace
[B87] Apply research findings and understand
the benefit risk [e.g. pre-clinical, clinical trials,
experimental clinical-pharmacological research
and risk management] (n = 34)
12.5 5 20.9 10.2 9.1 0 20.4 0.03
[B90] Ensure appropriate quality control tests are
performed and managed appropriately (n = 39)
12.5 0 25.6 11.9 9.1 9.1 22.8 0.01
[B95] Initiate and implement audit and research
activities (n = 33)
12.5 5 20.9 9 9.1 0 15.78 0.11
Acad. academic pharmacy, Admin. administrative pharmacy, Comm. community pharmacy, Hosp. hospital pharmacy, Indus. industrial pharmacy
aIncludes areas of pharmacy practice with fewer than 20 replies (these were pharmacy information [11], military and emergency pharmacy [2] and
laboratory and medicines control pharmacy [4])
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highlights the need to scale up efforts to build research
capacity in this region.
Of particular interest is the finding that a high percentage
(N > 15%) of community pharmacists from the countries
represented in this survey ranked two dispensing-related
behaviours: B13 (document and act upon dispensing errors)
and B14 (implement and maintain a dispensing error report
system and a near miss report system) ‘not relevant’ to
practice. This suggests community pharmacy respondents
from these countries do not routinely carry out these activ-
ities although this may have been due to the response rate
and/or that the pharmacists were self-selecting. However,
available evidence suggests this may also be related to the
peculiarities of community pharmacy practice in countries
with severe health workforce shortages such as Nigeria [43]
and Zambia [44]. Studies show that dispensing activities in
community pharmacies in Nigeria are mainly carried out
by pharmacy assistants and in some instances, by sales
personnel or clerks [43].
Furthermore, the finding may also be related to evidence
that suggest that many countries including those in Africa
either lack a defined medication error reporting system
[45, 46] or where available such systems are primarily
independent and/or based within a specific healthcare
facility [45, 47]. Given the broad similarities in pharmacy
practice reported in countries within the African region
Table 10 Distribution of the ‘not relevant’ ratings in relation to patient-facing component in area of pharmacy practice for the 10
behaviours showing disagreement
Cluster Competency Behaviour Patient-facing sectors* (N%) Non patient-facing sectors¶ (N%) χ2 value p
Not
relevant
Low
relevance
Relevant Not
relevant
Low
relevance
Relevant
Pharmaceutical
care
Assessment
of medicines
[B6] Identify, prioritise and
act upon medicine-medicine
interactions; medicine-disease
interactions; medicine-patient
interactions; medicine-food
interactions (n = 43)
9.1 21.1 69.8 18.2 22.7 59.1 6.3 0.04
Dispensing [B13] Document and act upon
dispensing errors (n = 50)
11.4 11.4 77.2 18.2 11.4 70.5 2.8 0.25
[B14] Implement and maintain
a dispensing error report
system and a ‘near misses’
report system (n = 43)
10.1 13.4 76.5 14.8 6.8 78.4 3.87 0.15
Medicines [B20] Package medicines to
optimise safety [ensuring
appropriate re-packaging and
labelling of the medicines]
(n = 39)
7.4 11.7 80.9 19.3 13.6 67 11.45 0.003
Organisation
and
management
Budget and
reimbursement
[B32] Ensure appropriate claim
for the reimbursement (n = 40)
10 18.4 71.6 19.2 10.3 70.5 6.56 0.04
[B34] Ensure proper reference
sources for service
reimbursement (n = 34)
9.2 16.8 74 14.1 17.9 67.9 1.72 0.44
Work place
management
[58] Ensure the production
schedules are appropriately
plan and manage (n = 35)
9.6 18.4 72 14.1 7.7 78.2 5.74 0.06
Professional
and personal
Quality
assurance and
research in the
workplace
[B87] Apply research findings
and understand the benefit
risk [e.g. pre-clinical, clinical
trials, experimental clinical-
pharmacological research
and risk management] (n = 34)
11.7 18.2 82.4 9.5 8.1 70.1 5.02 0.08
[B90] Ensure appropriate
quality control tests are
performed and managed
appropriately (n = 39)
14.3 21.2 64.5 8.1 6.8 85.1 11.72 0.003
[B95] Initiate and implement
audit and research activities
(n = 33)
11.3 19.9 68.8 9.5 8.1 82.4 6.19 0.05
*Pharmacy areas involving daily patient interactions including hospital and community pharmacy
¶Pharmacy areas not involving daily patient interactions including industrial, academic, administrative, laboratory and medicine control, and pharmacy information
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[48] and published reports of high incidence of patient
harm due to medication errors in some of the countries
represented in this survey [49, 50]. This finding underscores
the need to review current practice and incorporate robust
dispensing and medication error reporting processes in
community practice with oversight functions by pharma-
cists in order to assure patient safety.
Homogeneity in sample responses and the overall
survey results indicate minimal disparity between coun-
tries in perception of relevance to practice for majority
of the behaviours in the GbCF v1. This finding corrobo-
rates evidence from previous research [26] and provides
evidence that was previously lacking on the relevance of
the GbCF v1 competencies in these countries. The
finding is in consonance with similar evidence from the
field of medicine that demonstrates the relevance of the
Canadian CanMEDS Physician Competency Framework
to medical practice in the Netherlands [51], Denmark
[52, 53] and Australia [54]. It is also in line with
evidence from studies that show consensus between
countries in Europe on the relevance of a core set of com-
petencies for pharmacy education and practice [42, 55].
Although evidence from global studies have shown
that continuous professional development (CPD) is
mandatory in many countries in Africa, none of the
countries represented in this survey have reported the
availability of a validated competency framework for
early career pharmacy practice [7, 56]. Studies
conducted in Ghana, Ethiopia and Sudan suggest that
the lack of a structured post-registration pathway for
skills development contribute to the comparatively lower
levels of job satisfaction shown by early career pharma-
cists in these countries [57–59]. Our findings therefore
provide preliminary evidence on the validity of a core set
of competencies that can be further adapted to country
context and used to design skill development and learn-
ing activities for pre- and in-service early career phar-
macy practitioners in these countries. Our findings also
suggests the feasibility of adapting the GbCF v1 to de-
velop country-specific frameworks for use in facilitating
performance improvement and identifying learning
needs particularly in the four countries with compara-
tively high number of replies in this study.
This study has some limitations. The length of the
survey questionnaire (105 questions presented over
six pages) may have negatively impacted on the num-
ber of replies received. Findings from a meta-analysis
of randomised controlled trials show that the odds of
a response decreases by more than half as the
number of pages of a survey questionnaire increases
[OR 0.39, 95% CI 0.34 to 0.45] [60]. This was particu-
larly obvious with the consistent decrease in number
of replies per additional competency cluster in the
survey questionnaire (Additional file 1). Nonetheless,
research also demonstrates that the variation in response
rates per page of a questionnaire does not affect the qual-
ity of the overall responses received [61].
Online surveys are generally associated with low
response rates particularly because it restricts the
target populations to individuals with internet access
[62, 63]. This implies that potential respondents with-
out Internet access were excluded from this survey, a
feature that is significant given that our study was
conducted in countries that have been shown to have
comparatively higher cost and lower Internet accessi-
bility [64, 65]. However, the geographical location of
the survey population, limited resources and time
available for this research precluded the use of a tele-
phone or postal survey. Participant self-selection and
the non-probabilistic sample obtained via the purpos-
ive and snowball sampling technique in our study
likely limits the generalisability of our findings. Stud-
ies show that self-selected participants are likely to be
more intrinsically motivated than the general popula-
tion [66]. This non-random sampling method was
undertaken due to challenges with obtaining a sam-
pling frame for the respective countries. For this same
reason, it was difficult to estimate an optimal sample
size a priori and to calculate a response rate. In spite
of these limitations, the methods used in our study
are established and pragmatic evidence-based ap-
proaches in pharmacy practice research [26, 38–40].
Furthermore, given that our study was an exploratory
survey, our findings provide useful information on
pharmacists’ perception of relevance to practice of the
competencies and behaviours contained in the GbCF
v1 framework in the countries represented.
Further work is necessary to qualitatively explore
expert opinion and obtain insight from other stake-
holders including policy-makers and pharmacy leaders
on the validity of these competencies in the respective
countries. Also, a larger scale validation study is
needed to obtain further inputs from practitioners in
non-patient-facing roles such as industrial, administra-
tive and academic pharmacy in this region. This will
provide an opportunity for further review of the
GbCF v1 competencies in relation to these specific
areas of practice.
Conclusion
The majority (90%) of the competencies in the framework
as relevant to practice for the respondents in this survey,
although there are some emergent differences in weighting
of relevance between the countries represented. Overall,
the findings provide preliminary evidence that was previ-
ously lacking on the relevance of the GbCF v1 competen-
cies to pharmacy practice in these countries.
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